PPT-Biomarkers in the Brain Oxygen Optimization in Severe TBI Study

PIs Ramon DiazArrastia MD PhD and Frederick Korley MD PhD The Need Limited objective tools for monitoring secondary brain injury Scientific Rationale Preliminary evidence Korley et al J . A CASE REVIEW. PRIMARY SURVEY. Intubated-not initiating RR. Severe dysoxygenation-PaO2 mid 80’s on 100% FIO2 PEEP 14. Extremities cold pale/flaccid; peripheral pulses weak-. Temp 32.3 HR 134ST BP 93/66. Expanding the Horizons. Basics of Biomarkers in RA. Biomarkers in ACR/EULAR RA Criteria. Discordance of Common RA Biomarkers. RA Practice Performance Project (RAPP). Framing the Discussion. Using ACPA Testing to Diagnose RA. 4thEdition2TABLE OF CONTENTSPREFACECKNOWLEDGEMENTSUNDING OURCEISCLAIMER OF IABILITYONFLICT OF NTEREST ISCLOSUREUTHORSREFACEINTRODUCTIONRAIN RAUMA ESEARCHURRENT ONDITIONSHE RAIN RAUMA OUNDATIONOSITIONH Optimist. Department of Biochemistry, Molecular Biology and Biophysics. Institute on Biology of Aging and Metabolism. lniedern. @. umn.edu. Utility of mice in biomarker discovery. Strength . of mice. Development of a Multi-Modal . CLASSIFICATION SCHEME FOR Brain . Injury . Vikalpa Dammavalam, BS, Senior Project Coordinator. Sam Daly, BA, Research Assistant. Disclosure Policy. It is the policy of Hennepin County Medical Center to ensure balance, independence, objectivity and scientific rigor in all its sponsored educational activities. All faculty participating in sponsored programs are expected to disclose to the audience any real or apparent conflicts of interest to the content of their presentation. Our speaker has indicated that they have financial relationships to disclose related to this presentation.. TBI--Phase . 3. Protocol Introduction and Scientific Rationale. Ramon Diaz-Arrastia, MD, PhD. Professor of Neurology, University of Pennsylvania. BOOST-3 Study Chair. Does . BOOSTing. Cerebral Oxygenation Boost TBI Outcomes?. Presented by: . Dr. Puneet Opal . Dr. Hayley McLoughlin. A Virtual Event. March 17-19, 2022. DISCLAIMER. 2022 AAC. A Virtual Event. March 17-19. PRESENTER DISCLOSURES. Dr. Puneet Opal (Northwestern University). Incidence of Neurologic Complications of COVID-19 and Its Supportive Treatments. Colbey W. Freeman, MD; Jonathan Masur, MD; . Mougnyan. Cox, MD; . Suyash. Mohan, MD. Background. Coronavirus disease 2019 (COVID-19) is most known for causing pneumonia. . Selection of AD-related . biomarkers . for compound . measure computation . Abbreviations:. DMN= Default Mode Network; ILF/SLF=Inferior/Superior Lateral Fasciculi; LPC/RPC= Left/Right Parietal Cortex; . Leyen. Vu, DO. Sept. 8. th. , 2018. WSU Cougar Health Services. WSU Athletics Team Physician. Objectives. Need for objective measures for concussion. Identify characteristics of ideal serum biomarkers for concussion. Ramon Diaz-Arrastia, MD, PhD, Scientific PI. Lori Shutter, MD, Clinical PI. William Barsan, MD, Contact PI, CCC SIREN. Sharon Yeatts, PhD, Statistical PI, DCC SIREN. Brain Tissue Oxygen Monitors. FDA-approval:. Protocol Training. Ava Puccio, RN, PhD; Anita Fetzick, RN, MSN; Lori Shutter, MD. University of Pittsburgh / UPMC. Subject Identification: Helpful Hints for Screening. Screening for Enrollment. A screening log should be maintained by each site. Resident Board Review. July 6, 2010. Definition. A condition in which the core body temperature is below the normal physiologic parameters for an individual species. Classification. Primary. Subnormal temperature caused by excessive exposure to low environmental temperatures. B. rain . I. njury . T. reatment Trial: A Multicenter Phase II Adaptive Clinical Trial. . Gaylan. . Rockswold. , MD, PhD, Principal Investigator. Thomas Bergman, MD, Site Principal Investigator. Overview.